Expression of kallikrein-related peptidases (KRP/hK5, 7, 6, 8) in subtypes of human lung carcinoma

International Immunopharmacology

Volumn 8, Issue 2, 2008, Pages 300-306

  Singh, Jasmine ^a   Naran, Anupam ^b   Misso, Neil L ^a   Rigby, Paul J ^a   Thompson, Philip J ^a   Bhoola, Kanti D ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

Carcinoids; Kallikrein related peptidases; KRP hK5 8; Non small cell lung carcinoma; Small cell lung carcinoma

Indexed keywords

KALLIKREIN; KALLIKREIN 5; KALLIKREIN 6; KALLIKREIN 7; NEUROPSIN; PEPTIDASE; UNCLASSIFIED DRUG;

ARTICLE; BRAIN; BRIGHT FIELD MICROSCOPY; CARCINOID; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPEROXIDASE STAINING; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN; SQUAMOUS CELL CARCINOMA; SUBMANDIBULAR GLAND;

BRAIN; HUMANS; KALLIKREINS; LUNG; LUNG NEOPLASMS; SALIVARY GLANDS; SKIN;

EID: 37549037823     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2007.08.015     Document Type: Article

References (32)

1. Parkin D.M., Pisani P., and Ferlay J. Global cancer statistics. CA Cancer J Clin 49 (1999) 33-64
2. Doll R., Peto R., Wheatley K., Gray R., and Sutherland I. Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ 309 (1994) 901-911
3. Doll R., Peto R., Boreham J., and Sutherland I. Mortality from cancer in relation to smoking: 50 years observations on British doctors. Br J Cancer 92 (2005) 426-429
4. Zitting A., Husgafvel-Pursianen K., and Rantanen J. Environmental tobacco smoke - a major preventable cause of impaired health at work. Scand J Work Environ Health 28 Suppl 2 (2002) 3-6
5. Boffetta P. Epidemiology of environmental and occupational cancer. Oncogene 23 (2004) 6392-6403
6. Travis W.D., Brambilla E., Müller-Hermelink H.K., and Harris C.C. Pathology and genetics of tumours of the lung, pleura, thymus and heart. World Health Organization Classification of Tumours (2004), IARC Press, Lyon, France
7. Lundwall A., Band V., Blaber M., Clements J.A., Courty Y., Diamandis E.P., et al. A comprehensive nomenclature for serine proteases with homology to tissue kallikreins. Biol Chem 387 (2006) 637-641
8. Chee J, Singh J, Naran A, Misso NL, Thompson PJ, Bhoola KD. Novel expression of kallikreins, kallikrein-related peptidases and kinin receptors in human pleural mesothelioma. Biol Chem; In press, doi:10.1515/BC.2007.139 [Electronic publication ahead of print].
9. Bhoola K.D., Figueroa C.D., and Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev 44 (1992) 1-80
10. Bhoola K.D., and Fink E. Kallikrein-kinin cascade. In: Laurent G.J., and Shapiro S.D. (Eds). Encyclopedia of Respiratory Medicine. vol 2 (2005), Elsevier Ltd, Oxford, UK 483-493
11. Mahabeer R., and Bhoola K.D. Kallikrein and kinin receptor genes. Pharmacol Ther 88 (2000) 77-89
12. Clements J., Hooper J., Dong Y., and Harvey T. The expanded human kallikrein (KLK) gene family: genomic organization, tissue-specific expression and potential functions. Biol Chem 382 (2001) 5-14
13. Clements J.A., Willemsen N.M., Myers S.A., and Dong Y. The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers. Crit Rev Clin Lab Sci 441 (2000) 265-312
14. Bhoola K., Ramsaroop R., Plendl J., Cassim B., Dlamini Z., and Naicker S. Kallikrein and kinin receptor expression in inflammation and cancer. Biol Chem 382 (2001) 77-89
15. Diamandis E.P., Yousef G.M., Luo L.Y., Magklara A., and Obiezu C.V. The new human kallikrein gene family: implications in carcinogenesis. Trends Endocrinol Metab 11 (2000) 54-60
16. Borgoño C.A., Michael I.P., and Diamandis E.P. Human tissue kallikreins: physiologic roles and applications in cancer. Mol Cancer Res 2 (2004) 257-280
17. Obiezu C.V., and Diamandis E.P. Human tissue kallikrein gene family: applications in cancer. Cancer Lett 224 (2005) 1-22
18. Bhattacharjee A., Richards W.G., Staunton J., Li C., Monti S., Vasa P., et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A 98 (2001) 13790-13795
19. Planque C., de Monte M., Guyetant S., Rollin J., Desmazes C., Panel V., et al. KLK5 and KLK7, two members of the human tissue kallikrein family, are differentially expressed in lung cancer. Biochem Biophys Res Commun 329 (2005) 1260-1266
20. Planque C., Aïnciburu M., Heuzé-Vourc'h N., Regina S., de Monte M., and Courty Y. Expression of the human kallikrein genes 10 (KLK10) and 11 (KLK11) in cancerous and non-cancerous lung tissues. Biol Chem 387 (2006) 783-788
21. Brattsand M., and Egelrud T. Purification, molecular cloning, and expression of a human stratum corneum trypsin-like serine protease with possible function in desquamation. J Biol Chem 274 (1999) 30033-30040
22. Caubet C., Jonca N., Brattsand M., Guerrin M., Bernard D., Schmidt R., et al. Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7. J Invest Dermatol 122 (2004) 1235-1244
23. Little S.P., Dixon E.P., Norris F., Buckley W., Becker G.W., Johnson M., et al. Zyme, a novel and potentially amyloidogenic enzyme cDNA isolated from Alzheimer's disease brain. J Biol Chem 272 (1997) 25135-25142
24. Yoshida S., Taniguchi M., Hirata A., and Shiosaka S. Sequence analysis and expression of human neuropsin cDNA and gene. Gene 213 (1998) 9-16
25. Ogawa K., Yamada T., Tsujioka Y., Taguchi J., Takahashi M., Tsuboi Y., et al. Localization of a novel type trypsin-like serine protease, neurosin, in brain tissues of Alzheimer's disease and Parkinson's disease. Psychiatry Clin Neurosci 54 (2000) 419-426
26. Franklin W.A. Diagnosis of lung cancer: pathology of invasive and preinvasive neoplasia. Chest 117 (2000) 80S-89S
27. Borgono C.A., and Diamandis E.P. The emerging roles of human tissue kallikreins in cancer. Nat Rev Cancer 4 (2004) 876-890
28. Dong Y., Kaushal A., Brattsand M., Nicklin J., and Clements J.A. Differential splicing of KLK5 and KLK7 in epithelial ovarian cancer produces novel variants with potential as cancer biomarkers. Clin Cancer Res 9 (2003) 1710-1720
29. Michael I.P., Kurlender L., Memari N., Yousef G.M., Du D., Grass L., et al. Intron retention: a common splicing event within the human kallikrein gene family. Clin Chem 51 (2005) 506-515
30. Tan O.L., Whitbread A.K., Clements J.A., and Dong Y. Kallikrein-related peptidase (KLK) family mRNA variants and protein isoforms in hormone-related cancers: do they have a function?. Biol Chem 387 (2006) 697-705
31. Scarisbrick I.A., Blaber S.I., Lucchinetti C.F., Genain C.P., Blaber M., and Rodriguez M. Activity of a newly identified serine protease in CNS demyelination. Brain 125 (2002) 1283-1296
32. Sher Y.P., Chou C.C., Chou R.H., Wu H.M., Wayne Chang W.S., Chen C.H., et al. Human kallikrein 8 protease confers a favorable clinical outcome in non-small cell lung cancer by suppressing tumor cell invasiveness. Cancer Res 66 (2006) 11763-11770